About NIOX
NIOX is a company based in Sweden founded in 1997. It operates as a Direct-to-Consumer (D2C), and Professional Services. The company has 91 employees as of December 31, 2024. NIOX offers products and services including NIOX VERO® and FeNO Learn App. NIOX operates in a competitive market with competitors including Bioxhale, GattyInstruments and Aerocrine, among others.
- Headquarter Sweden
- Employees 91 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Niox Group Plc
-
Annual Revenue
$52.37 M (USD)13.59as on Dec 31, 2024
-
Net Profit
$4.64 M (USD)-65.42as on Dec 31, 2024
-
EBITDA
$14.91 M (USD)32.22as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
91
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of NIOX
NIOX is a publicly listed company on the LSE with ticker symbol NIOX in UK, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of NIOX
NIOX offers a comprehensive portfolio of products and services, including NIOX VERO® and FeNO Learn App. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
FeNO testing device for airway inflammation assessment used.
Educational app for learning about FeNO testing provided.
Funding Insights of NIOX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by NIOX
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NIOX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Niox Comparisons
Competitors of NIOX
NIOX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bioxhale, GattyInstruments and Aerocrine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provides breath samplers and analysis services for health diagnostics and testing.
|
|
| domain | founded_year | HQ Location |
Researches, develops, and markets mobile respiratory analyzers for consumers and healthcare.
|
|
| domain | founded_year | HQ Location |
Point-of-care devices for airway inflammation measurement are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Niox
Frequently Asked Questions about NIOX
When was NIOX founded?
NIOX was founded in 1997.
Where is NIOX located?
NIOX is headquartered in Sweden.
Who is the current CEO of NIOX?
Jonathan Emms is the current CEO of NIOX.
How many employees does NIOX have?
As of Dec 31, 2024, the latest employee count at NIOX is 91.
What is the annual revenue of NIOX?
Annual revenue of NIOX is $52.37M as on Dec 31, 2024.
What does NIOX do?
NIOX is engaged in the development and distribution of FeNO testing devices, primarily through its flagship product, NIOX VERO, which aids in assessing airway inflammation for asthma care. The company serves healthcare professionals in primary and secondary care settings, as well as clinical researchers globally. Solutions are provided for accurate and reliable diagnostic testing at the point of care. Additionally, educational resources and support are offered to enhance understanding of FeNO testing and its applications in asthma diagnosis and management across various healthcare sectors.
Who are the top competitors of NIOX?
NIOX's top competitors include Aerocrine, Bioxhale and GattyInstruments.
What products or services does NIOX offer?
NIOX offers NIOX VERO® and FeNO Learn App.
Is NIOX publicly traded?
Yes, NIOX is publicly traded on LSE under the ticker symbol NIOX.
What is NIOX's ticker symbol?
The ticker symbol of NIOX is NIOX on LSE.